Results 11 to 20 of about 110,250 (249)

Soft Tissue Sarcoma [PDF]

open access: yesJournal of the National Comprehensive Cancer Network, 2010
The soft-tissue sarcomas (STS) of childhood are a relatively rare and heterogeneous group of tumors that may occur anywhere in the body and respond quite differently to therapy. STSs account for 7.4% of all cancers in children younger than 20 years [1].
George D, Demetri   +23 more
openaire   +2 more sources

Soft tissue sarcomas [PDF]

open access: yesCurrent Problems in Surgery, 1996
Soft tissue sarcomas are relatively rare tumors with an annual incidence of 5000 to 6000 in the United States. The primary therapy is surgical resection with an adequate margin of normal tissue. For patients at high risk local control is improved with postoperative adjuvant radiation. Local recurrence rates vary depending on the anatomic site.
J J, Lewis, M F, Brennan
openaire   +4 more sources

Soft Tissue Sarcomas

open access: yesCA: A Cancer Journal for Clinicians, 2004
Sarcomas are a heterogeneous group of rare tumors that arise predominantly from the embryonic mesoderm. They present most commonly as an asymptomatic mass originating in an extremity but can occur anywhere in the body, particularly the trunk, retroperitoneum, or the head and neck.
Janice N, Cormier, Raphael E, Pollock
openaire   +2 more sources

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

open access: yesHepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou   +13 more
wiley   +1 more source

Immunotherapy in Soft-Tissue Sarcoma [PDF]

open access: yesCurrent Oncology, 2020
Soft-tissue sarcoma (sts) is a rare mesenchymal malignancy that accounts for less than 1% of all adult tumours. Despite the successful advancement of localized therapies such as surgery and radiotherapy, these tumours can, for many, recur—often with metastatic disease.
O, Ayodele, A R Abdul, Razak
openaire   +2 more sources

Soft-tissue Sarcomas

open access: yesIndian Journal of Orthopaedics, 2018
This article discusses the epidemiology, diagnosis, and management of primary soft-tissue sarcomas (STS). These musculoskeletal tumors are a rare and heterogeneous group of malignancies, which are best managed by multidisciplinary teams in specialist sarcoma referral centers.
Vodanovich, Domagoj Ante   +1 more
openaire   +3 more sources

Soft tissue sarcoma

open access: yesBMJ, 2016
#### What you need to know A 45 year old woman presented to her general practitioner several times over nine months with a gradually enlarging, hard lump in her anterior thigh. An ultrasound scan showed a solid intramuscular mass in the anterior compartment of her thigh, prompting a two week wait referral to the regional sarcoma diagnostic clinic ...
Eastley, Nicholas Charles   +2 more
openaire   +3 more sources

Soft tissue sarcomas

open access: yesEuropean Journal of Cancer, 1997
The soft tissue sarcomas (STS) constitute approximately 15% of all canine and 7% of all feline skin and subcutaneous tumors. STS are tumors that arise from a variety of mesenchymal tissues. The aggressive nature of STS in cats, especially those tumors occurring after vaccination, suggests that novel therapies should be investigated.
openaire   +4 more sources

Wyniki leczenia operacyjnego chorych na chrzęstniakomięsaki miednicy z oszczędzeniem kończyny

open access: yesNowotwory, 2021
Analizie poddano 53 kolejnych chorych na chondrosarcoma (ChSa) kości miednicy i kości krzyżowej leczonych operacyjnie w Klinice Nowotworów Tkanek Miękkich, Kości i Czerniaków Narodowego Instytutu Onkologii im.
Andrzej Pieńkowski   +9 more
doaj   +1 more source

Diagnostic Value of Serum LncRNAs for Bone Metastasis in Lung Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2022
Objective To investigate the expression of lncRNA HOTAIR, HOTAIR, CRNDE and AFAP1-AS1 in lung cancer patients with bone metastasis (LCWBM), and to elucidate the diagnostic value of lncRNAs for LCWBM. Methods Serum was collected from 38 LCWBM patients and
ZHANG Peng   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy